Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Skin Cream Recalled for Microbial Contamination
09/19/2024
Prequel Skin is recalling more than 30 000 tubes of Barrier Therapy Skin Protectant Cream because of microbial contamination.
Prequel Skin is recalling more than 30 000 tubes of Barrier Therapy Skin Protectant Cream because of microbial contamination.
Prequel Skin is recalling more...
09/19/2024
Pharmacy Learning Network
News
Revolutionary Cell Therapy May Eliminate Need for Immunosuppressants in Liver Transplant Recipients
09/16/2024
Donor immune cells may reduce or eliminate the need for immunosuppressants in liver transplant recipients, potentially revolutionizing post-transplant care, according to a study published in Science Translational Medicine.
Donor immune cells may reduce or eliminate the need for immunosuppressants in liver transplant recipients, potentially revolutionizing post-transplant care, according to a study published in Science Translational Medicine.
Donor immune cells may reduce or...
09/16/2024
Pharmacy Learning Network

Advertisement

News
Recall for Tablets Distributed in 2 States
09/13/2024
Preferred Pharmaceuticals Inc. is recalling 266 bottles of ibuprofen tablets distributed in California and Nevada, according to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report. The affected tablets failed to...
Preferred Pharmaceuticals Inc. is recalling 266 bottles of ibuprofen tablets distributed in California and Nevada, according to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report. The affected tablets failed to...
Preferred Pharmaceuticals Inc....
09/13/2024
Pharmacy Learning Network
News
Impurity Prompts Tablet Recall
09/13/2024
Dr Reddy’s Laboratories Inc. is recalling 150 040 bottles of IBU (ibuprofen) tablets because of an unknown impurity. According to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report, testing revealed impurity...
Dr Reddy’s Laboratories Inc. is recalling 150 040 bottles of IBU (ibuprofen) tablets because of an unknown impurity. According to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report, testing revealed impurity...
Dr Reddy’s Laboratories Inc. is...
09/13/2024
Pharmacy Learning Network
News
Drug Recalled for Failing Dissolution Testing
09/13/2024
Glenmark Pharmaceuticals Inc. USA is recalling 2404 bottles of indomethacin extended-release capsules distributed throughout the United States by Taro Pharmaceuticals USA, Hawthorne, New York. According to the September 4, 2024, US Food and...
Glenmark Pharmaceuticals Inc. USA is recalling 2404 bottles of indomethacin extended-release capsules distributed throughout the United States by Taro Pharmaceuticals USA, Hawthorne, New York. According to the September 4, 2024, US Food and...
Glenmark Pharmaceuticals Inc....
09/13/2024
Pharmacy Learning Network

Advertisement

News
Comprehensive Review Reveals Substantial Burden of Respiratory Syncytial Virus in Adults Worldwide
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
Elderly Patient With Doctor
News
Patients with Multiple Sclerosis Less Likely to Develop Alzheimer Disease
09/03/2024
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.
Patients with MS had about half...
09/03/2024
Neurology
News
Class I Recall for Intravenous Solution
08/28/2024
B. Braun Medical Inc. is recalling over 60 000 containers of 0.9% sodium chloride injection for the potential presence of particulate matter and fluid leakage.
B. Braun Medical Inc. is recalling over 60 000 containers of 0.9% sodium chloride injection for the potential presence of particulate matter and fluid leakage.
B. Braun Medical Inc. is...
08/28/2024
Pharmacy Learning Network

Advertisement

News
Label Mix-Up Prompts Class I Recall for Injection
08/28/2024
Hikma Pharmaceuticals USA Inc. is recalling over 30 000 bags of acetaminophen injection after a bag labeled dexmedetomidine HCl injection was found inside an overwrap labeled acetaminophen injection.
Hikma Pharmaceuticals USA Inc. is recalling over 30 000 bags of acetaminophen injection after a bag labeled dexmedetomidine HCl injection was found inside an overwrap labeled acetaminophen injection.
Hikma Pharmaceuticals USA Inc....
08/28/2024
Pharmacy Learning Network
News
OTC Migraine Relief Tablets Under Class I Recall
08/28/2024
Aurobindo Pharma USA Inc., on behalf of AuroHealth, is recalling bottles of Healthy Living migraine relief tablets because bottles sold through Amazon are missing the manufacturer’s label, including drug fact information.
Aurobindo Pharma USA Inc., on behalf of AuroHealth, is recalling bottles of Healthy Living migraine relief tablets because bottles sold through Amazon are missing the manufacturer’s label, including drug fact information.
Aurobindo Pharma USA Inc., on...
08/28/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use